| A molecular perspective of CTLA-4 function WA Teft, MG Kirchhof, J Madrenas Annu. Rev. Immunol. 24, 65-97, 2006 | 650 | 2006 |
| ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists J Madrenas, RL Wange, JL Wang, N Isakov, LE Samelson, RN Germain Science 267 (5197), 515-518, 1995 | 630 | 1995 |
| Human embryonic stem cells possess immune‐privileged properties L Li, ML Baroja, A Majumdar, K Chadwick, A Rouleau, L Gallacher, ... Stem Cells 22 (4), 448-456, 2004 | 440 | 2004 |
| Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis JD Spence, V Coates, H Li, A Tamayo, C Munoz, DG Hackam, M DiCicco, ... Archives of neurology 67 (2), 180-186, 2010 | 437 | 2010 |
| CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression BM Carreno, F Bennett, TA Chau, V Ling, D Luxenberg, J Jussif, ... The Journal of Immunology 165 (3), 1352-1356, 2000 | 355 | 2000 |
| Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality A Gagnon, MS Miller, SA Hallman, R Bourbeau, DA Herring, DJD Earn, ... PloS one 8 (8), e69586, 2013 | 218 | 2013 |
| Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool J Garcia‐Castro, C Trigueros, J Madrenas, JA Perez‐Simon, R Rodriguez, ... Journal of cellular and molecular medicine 12 (6b), 2552-2565, 2008 | 217 | 2008 |
| The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide–MHC molecule ligands J Madrenas, LA Chau, J Smith, JA Bluestone, RN Germain The Journal of experimental medicine 185 (2), 219-230, 1997 | 214 | 1997 |
| Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications GE Gardiner, C Heinemann, ML Baroja, AW Bruce, D Beuerman, ... International Dairy Journal 12 (2-3), 191-196, 2002 | 169 | 2002 |
| Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome TA Chau, ML McCully, W Brintnell, G An, KJ Kasper, ED Vinés, P Kubes, ... Nature medicine 15 (6), 641-648, 2009 | 166 | 2009 |
| The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i‐AAA protease YME1L T Wai, S Saita, H Nolte, S Müller, T König, R Richter‐Dennerlein, ... EMBO reports 17 (12), 1844-1856, 2016 | 161 | 2016 |
| Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial biogenesis and function DA Christie, CD Lemke, IM Elias, LA Chau, MG Kirchhof, B Li, EH Ball, ... Molecular and cellular biology 31 (18), 3845-3856, 2011 | 148 | 2011 |
| Surface cytotoxic T lymphocyte–associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation PJ Darlington, ML Baroja, TA Chau, E Siu, V Ling, BM Carreno, ... The Journal of experimental medicine 195 (10), 1337-1347, 2002 | 129 | 2002 |
| Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Gα11-dependent, PLC-β-mediated pathway C Bueno, CD Lemke, G Criado, ML Baroja, SSG Ferguson, ... Immunity 25 (1), 67-78, 2006 | 128 | 2006 |
| Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A ML Baroja, L Vijayakrishnan, E Bettelli, PJ Darlington, TA Chau, V Ling, ... The Journal of Immunology 168 (10), 5070-5078, 2002 | 124 | 2002 |
| A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus V Frodermann, TA Chau, S Sayedyahossein, JM Toth, DE Heinrichs, ... Journal of infectious Diseases 204 (2), 253-262, 2011 | 120 | 2011 |
| Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation RN Madrenas Joaquin, Germain Seminars in immunology 8 (2), 83-101, 1996 | 120 | 1996 |
| Metalloproteinases Are Involved in Lipopolysaccharide–and Tumor Necrosis Factor-–Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression MH Khandaker, G Mitchell, L Xu, JD Andrews, R Singh, H Leung, ... Blood, The Journal of the American Society of Hematology 93 (7), 2173-2185, 1999 | 114 | 1999 |
| Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor LA Chau, JA Bluestone, J Madrenas The Journal of experimental medicine 187 (10), 1699-1709, 1998 | 112 | 1998 |
| Evolving the theory and praxis of knowledge translation through social interaction: a social phenomenological study CL McWilliam, A Kothari, C Ward-Griffin, D Forbes, B Leipert, ... Implementation Science 4, 1-14, 2009 | 109 | 2009 |
